Gilead Sciences (GILD) Payables (2009 - 2026)
Gilead Sciences posted quarterly Payables of $645.0 million for Q1 2026, down 12.48% year-on-year from $737.0 million in Q1 2025, and down 9.79% on a QoQ basis from $715.0 million in Q4 2025.
Gilead Sciences (GILD) has 18 years of Payables data on file, last reported at $645.0 million in Q1 2026.
- For the quarter ending Q1 2026, Payables fell 12.48% year-over-year to $645.0 million; the trailing twelve-month figure through Mar 2026 stood at $645.0 million (down 12.48% YoY), and the FY2025 full-year result was $715.0 million, down 14.17% from the prior year.
- Payables for Q1 2026 stood at $645.0 million, down from $715.0 million in the prior quarter.
- Across five years, Payables topped out at $905.0 million in Q4 2022 and bottomed at $537.0 million in Q2 2024.
- The 5-year median for Payables is $622.0 million (2023), against an average of $672.6 million.
- The widest annual swing landed in 2023, when Payables sank 39.23%; it then jumped 54.1% in 2024.
- A 5-year view of Payables shows it stood at $905.0 million in 2022, then tumbled by 39.23% to $550.0 million in 2023, then soared by 51.45% to $833.0 million in 2024, then slipped by 14.17% to $715.0 million in 2025, then retreated by 9.79% to $645.0 million in 2026.
- The last three Payables figures came in at $645.0 million (Q1 2026), $715.0 million (Q4 2025), and $808.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 5.03 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 27.92 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 33.77 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 6.01 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 2.94 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 645.00 Mn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 4.51 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 4.23 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 24.45 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 645.00 Mn |
| Dec 31, 2025 | 715.00 Mn |
| Sep 30, 2025 | 808.00 Mn |
| Jun 30, 2025 | 582.00 Mn |
| Mar 31, 2025 | 737.00 Mn |
| Dec 31, 2024 | 833.00 Mn |
| Sep 30, 2024 | 903.00 Mn |
| Jun 30, 2024 | 537.00 Mn |
| Mar 31, 2024 | 622.00 Mn |
| Dec 31, 2023 | 550.00 Mn |
| Sep 30, 2023 | 586.00 Mn |
| Jun 30, 2023 | 622.00 Mn |
| Mar 31, 2023 | 627.00 Mn |
| Dec 31, 2022 | 905.00 Mn |
| Sep 30, 2022 | 614.00 Mn |
| Jun 30, 2022 | 565.00 Mn |
| Mar 31, 2022 | 583.00 Mn |
| Dec 31, 2021 | 705.00 Mn |
| Sep 30, 2021 | 585.00 Mn |
| Jun 30, 2021 | 608.00 Mn |
| Mar 31, 2021 | 570.00 Mn |
| Dec 31, 2020 | 844.00 Mn |
| Sep 30, 2020 | 527.00 Mn |
| Jun 30, 2020 | 532.00 Mn |
| Mar 31, 2020 | 590.00 Mn |
| Dec 31, 2019 | 713.00 Mn |
| Sep 30, 2019 | 632.00 Mn |
| Jun 30, 2019 | 617.00 Mn |
| Mar 31, 2019 | 577.00 Mn |
| Dec 31, 2018 | 790.00 Mn |
| Sep 30, 2018 | 580.00 Mn |
| Jun 30, 2018 | 623.00 Mn |
| Mar 31, 2018 | 711.00 Mn |
| Dec 31, 2017 | 814.00 Mn |
| Sep 30, 2017 | 696.00 Mn |
| Jun 30, 2017 | 819.00 Mn |
| Mar 31, 2017 | 944.00 Mn |
| Dec 31, 2016 | 1.21 Bn |
| Sep 30, 2016 | 1.05 Bn |
| Jun 30, 2016 | 1.12 Bn |
| Mar 31, 2016 | 945.00 Mn |
| Dec 31, 2015 | 1.18 Bn |
| Sep 30, 2015 | 1.24 Bn |
| Jun 30, 2015 | 1.57 Bn |
| Mar 31, 2015 | 1.01 Bn |
| Dec 31, 2014 | 955.00 Mn |
| Sep 30, 2014 | 1.18 Bn |
| Jun 30, 2014 | 1.16 Bn |
| Mar 31, 2014 | 1.23 Bn |
| Dec 31, 2013 | 1.26 Bn |
| Sep 30, 2013 | 1.35 Bn |
| Jun 30, 2013 | 1.39 Bn |
| Mar 31, 2013 | 1.36 Bn |
| Dec 31, 2012 | 1.33 Bn |
| Sep 30, 2012 | 1.32 Bn |
| Jun 30, 2012 | 1.37 Bn |
| Mar 31, 2012 | 1.34 Bn |
| Dec 31, 2011 | 1.21 Bn |
| Sep 30, 2011 | 1.06 Bn |
| Jun 30, 2011 | 1.10 Bn |
| Mar 31, 2011 | 981.63 Mn |
| Dec 31, 2010 | 803.03 Mn |
| Sep 30, 2010 | 950.81 Mn |
| Mar 31, 2010 | 949.08 Mn |
| Dec 31, 2009 | 810.54 Mn |
| Sep 30, 2009 | 742.68 Mn |
| Jun 30, 2009 | 650.00 Mn |